SUMMARY
Inflammatory NF-kB/RelA activation is mediated by the three canonical inhibitors, IkBa, -b, and -3. We report here the characterization of a fourth inhibitor, nfkb2/p100, that forms two distinct inhibitory complexes with RelA, one of which mediates developmental NF-kB activation. Our genetic evidence confirms that p100 is required and sufficient as a fourth IkB protein for noncanonical NF-kB signaling downstream of NIK and IKK1. We develop a mathematical model of the four-IkB-containing NF-kB signaling module to account for NF-kB/RelA:p50 activation in response to inflammatory and developmental stimuli and find signaling crosstalk between them that determines gene-expression programs. Further combined computational and experimental studies reveal that mutant cells with altered balances between canonical and noncanonical IkB proteins may exhibit inappropriate inflammatory gene expression in response to developmental signals. Our results have important implications for physiological and pathological scenarios in which inflammatory and developmental signals converge.
INTRODUCTION
The transcription factor NF-kB plays critical roles in diverse physiological processes (Ghosh and Karin, 2002) and numerous human pathologies . The primary mediator of NF-kB transcriptional activity is a RelA:p50 heterodimer. Mouse knockout studies have confirmed that RelA is responsible for the expression of a large number of genes involved in inflammatory responses as well as in cell proliferation, cell adhesion, and tissue remodeling (Hoffmann and Baltimore, 2006) . NF-kB activity is inducible by a diverse range of stimuli (www.nf-kb.org); these include pathogen derived substances and intercellular mediators of inflammation, immune cell maturation, and secondary lymphoid organ development. Understanding the mechanisms that regulate NF-kB activity is critical for developing therapeutic strategies for many human diseases (Ghosh and Karin, 2002; Hoffmann and Baltimore, 2006; Karin et al., 2004) .
Induction of NF-kB/RelA activity in response to inflammatory stimuli does not require protein synthesis. Instead, early experiments distinguished between two activation mechanisms: a precursor processing mechanism or regulation by a separate inhibitor protein. The detergent deoxycholate was shown to liberate fully active kB-site DNA binding activity in unstimulated cells, suggesting the existence of a separate inhibitor protein(s), termed IkB (Baeuerle and Baltimore, 1988) . Three IkB proteins (IkBa, have been identified, which share the bona fide IkB properties of (1) binding NF-kB dimers, thereby inhibiting their DNA binding activity and retaining them in a latent state, and (2) allowing for NF-kB activation by undergoing stimulus-induced proteolysis. The canonical signaling pathway involves the stimulus-responsive phosphorylation of the IkBs by the NEMO and IKK2 containing kinase complex, which tags them for degradation via the ubiquitin-proteasome pathway. Several other IkB-like ankyrin-repeat containing NF-kB binding proteins have been reported to modulate nuclear NF-kB transcriptional activity on a subset of genes or, when overexpressed, prevent nuclear localization of NF-kB (Hatada et al., 1992; Inoue et al., 1992; Naumann et al., 1993) . However, during inflammatory signaling the dynamic control of NF-kB nucleocytoplasmic localization is mediated by the three classical IkB proteins. A detailed molecular understanding of the biochemical events has allowed for the construction of a mathematical model that recapitulates the experimentally observed signaling behavior in response to inflammatory stimuli (Hoffmann et al., 2002; Kearns et al., 2006; Werner et al., 2005) .
In contrast, a second NF-kB activation pathway is thought to regulate the activity of NF-kB/RelB dimers via a precursor processing mechanism. This signaling pathway is activated in response to developmental signals such as those transduced by lymphotoxin b receptor (LTbR) and RANK, which are required for lymph node and osteoclast genesis and homeostasis (Senftleben et al., 2001; Weih and Caamano, 2003) , or BAFFR, CD40, and CD27, which regulate B cell survival and proliferation (Ramakrishnan et al., 2004; Zarnegar et al., 2004) . The activation mechanism was shown to involve NF-kBinducing kinase (NIK) and IKK1-dependent phosphorylation of the nfkb2 gene product p100 (Dejardin et al., 2002) , which triggers its proteasomal processing. This partial proteolysis event removes a C-terminal ankyrin repeat domain (ARD) to generate the NF-kB protein p52 (Senftleben et al., 2001) . Interestingly, only newly synthesized p100 was shown to undergo processing to generate nuclear p52-containing nuclear NF-kB activities (Mordmuller et al., 2003) .
The physiological role of LTbR is to transduce signals from hematopoietically derived lymphoid tissue inducer cells expressing membrane bound lymphotoxin (LTab) to mesenchymal or stromal cells to initiate critical steps in lymph node development (Mebius, 2003; Rennert et al., 1998) . LTbR stimulation results in both RelA-and RelBcontaining NF-kB dimers (Muller and Siebenlist, 2003) . The vascular-cell adhesion molecule 1 (VCAM1), a prominent RelA target gene, mediates early steps in lymph node genesis, the formation of lymph node anlagen during embryogenesis. Subsequently, homing of B cells, whose interaction with stromal cells is critical for lymph node and splenic microarchitecture, requires lymphoid chemokines SLC/CCL21 and BLC/CXCL13, whose expression is thought to involve RelB (Bonizzi et al., 2004) . The maturation of spleen and lymph nodes and continued influx and organization of lymphocytes in these secondary lymphoid organs during adulthood is also dependent on LTbR signaling and the expression of the RelA target gene Mad-CAM (Browning et al., 2005) . The phenotypes of knockout mice reflect the requirement of both RelA-and RelBcontaining NF-kB activities. While RelA deficiency results in a complete absence of lymph nodes in newborn mice indicating an early organogenic defect (Alcamo et al., 2002 ), RelB appears to be required for their maintenance as RelB-deficient mice exhibit deterioration of nodes following birth (Weih et al., 2001) .
Despite the importance of RelA activity in lymph node genesis, the molecular mechanism responsible for LTbR-induced RelA:p50 dimer activation has remained unclear. Both an IkB-dependent (Muller and Siebenlist, 2003) and an IkB-independent (Jiang et al., 2003) activation mechanism have been proposed, and for CD27 signaling the noncanonical signal transducer NIK has been implicated (Ramakrishnan et al., 2004) . Here we report the existence of a fourth bona fide IkB protein that mediates RelA:p50 activation in response to noncanonical NF-kB signaling pathways. Reconstruction of the signaling mechanism in a mathematical model allowed us to demonstrate that this mechanism is sufficient to account for the experimental observables and explore signaling crosstalk in cells exposed to diverse NF-kB inducing stimuli.
RESULTS AND DISCUSSION
NF-kB/RelA Activation without IkB Degradation Current pathway maps of LTbR signaling posit that IKK1-dependent processing of the nfkb2 gene product p100 to p52 results in the nuclear localization of a RelB:p52 dimer. However, the activation mechanism of RelA-containing dimers remains unclear and is generally thought to involve the IKK2-IkB-NF-kB signaling module that also allows for signal transduction of inflammatory stimuli ( Figure 1A ). As we previously recapitulated NF-kB/RelA activation in response to tumor necrosis factor receptor (TNFR) and Toll-like receptor (TLR)-4 stimulation in a mathematical model, we set out to examine the mechanism of NF-kB/ RelA activation downstream of LTbR in a genetically tractable cell culture system to similarly reconstitute the underlying signaling mechanism in silico.
We stimulated mouse embryonic fibroblasts (MEF) with an agonistic antibody raised against LTbR that was shown to functionally complement for the genetic absence of LTab (Rennert et al., 1998) . Using subsaturating concentrations of antibody that resulted in specific signaling events (Figures S1A-S1H), we detected nuclear NF-kB DNA binding activity ( Figure 1B ) that consisted of both RelA:p50 and RelB:p50 dimers ( Figure 1C ), as previously described (Derudder et al., 2003) .
One of the critical steps in NF-kB/RelA activation in response to inflammatory stimuli is NEMO-dependent IKK phosphorylation and degradation of RelA bound IkBs. Immunoprecipitated IKK activity could be detected in response to very low concentrations (0.01 ng/ml) of TNF ( Figure 1D , lanes 7-12), but, surprisingly, nonsaturating LTbR stimulation conditions did not elicit any NEMOassociated IKK activity ( Figure 1D, lanes 18-22) . Consistently, cytoplasmic immunoblotting revealed no decrease in IkB protein levels ( Figure 1E , lanes 8-11) and no inducible IkBa phosphorylation (Figures S1I and S1J). nfkb2 p100 Is an Inhibitor of NF-kB/RelA:p50 DNA Binding Activity These observations led us to search for novel factors that regulate NF-kB/RelA dimers in response to noncanonical stimuli. To this end we utilized a cell line deficient in the three canonical IkB proteins, IkBa, -b, and -3 (ikb À/À ). Initial biochemical characterization revealed that despite the loss of these known NF-kB inhibitors, only a small fraction of cellular RelA was constitutively nuclear, while the majority of RelA was still cytoplasmic (Figure 2A ), consistent with observations in IkB knockdown cells (Tergaonkar et al., 2005) . To investigate the molecular basis for cytoplasmic sequestration, we reconstituted a cell line also lacking the rela gene (ikb
) with a tandem epitope-tagged form of RelA (TAP-RelA) by retrovirusmediated transduction ( Figure S2A ). Tandem affinity purification of epitope-tagged RelA in nondenaturing conditions followed by silver staining of purified proteins separated on SDS-PAGE as well as mass-spectrometric analysis revealed nfkb1 p50 and nfkb2 p100 as the two major interacting proteins (Figure 2B ). Coimmunoprecipitation analysis confirmed that p100 was bound to RelA not only in IkBa/b/3-deficient ( Figures 2C and S2B , right panels) but also wild-type extracts ( Figures 2C and S2B , left panels). Interestingly, a comparison of immunoprecipitates of RelA and RelB revealed that p100 was distributed evenly between RelB and RelA bound complexes in wild-type cells ( Figure 2D) .
We employed the detergent deoxycholate (DOC) to disrupt the interaction of endogenous IkB proteins and NF-kB (Baeuerle and Baltimore, 1988) and reveal the DNA binding activity ( Figure 2E , compare lanes 1 and 2) of a RelA:p50 dimer ( Figure S2C , top panel) in cytoplasmic extracts prepared from unstimulated wild-type MEF. As expected, prior immunodepletion of IkBa from the extract removed the majority of latent NF-kB DNA binding activity (lane 3). However, immunodepletion of p100 also resulted in a significant loss in DOC-inducible DNA binding activity, while immunodepletion of p105 did not (lanes 4 and 5). These results suggest that a fraction of cytoplasmic RelA:p50 dimer is not bound to canonical IkB proteins but to p100. Strikingly, treating ikba
plasmic extracts with DOC liberated latent NF-kB DNA binding activity composed of RelA and p50 (Figures 2E, lanes 6 and 7, and S2C, bottom panel) . Prior immunodepletion of p100 specifically eliminated almost all of the DOC-induced DNA binding activity ( Figure 2E , lanes 8 and 9). These biochemical results prompted us to examine the RelA:p50-p100 interaction genetically. Lentiviral delivery of small hairpin RNA (shRNA) to ''knockdown'' nfkb2 expression in IkBa/b/3-deficient cells resulted in more than 90% reduction of p100/p52 protein levels ( Figure 2F , left panel). Importantly, electrophoretic mobility shift assay (EMSA) with nuclear extracts prepared from these ikb À/À / p100KD cells showed an $5-fold increase in the NF-kB activity over controls (Figures 2F, right panel, and S2E) . Supershift analysis confirmed that the majority of this DNA binding activity consisted of RelA:p50 dimers ( Figure 2G , data not shown). In sum, our results demonstrated that, analogous to the canonical IkB proteins, p100 is able to sequester RelA:p50 dimers in the cytoplasm and inhibit their DNA binding activity in a DOC-sensitive manner.
nfkb2 p100 Is a Stimulus-Responsive Regulator of NF-kB/RelA:p50 Activity We sought to examine the stimulus-responsive behavior of p100 bound to RelA:p50 dimers. By immunoprecipitating RelA in nondenaturing conditions from cellular extracts, we found that LTbR stimulation led to a decrease in RelA-associated p100 protein ( Figure 3A ), suggesting that p100 may mediate NF-kB/RelA activation in response to LTbR stimulation. Using a genetic approach, we found that LTbR stimulation of nfkb2 À/À cells were not only deficient in RelB activation as reported (Derudder et al., 2003; Lo et al., 2006) but that NF-kB/RelA activation was also abrogated ( Figure 3B , top panel, lanes 1-4). Reconstitution of nfkb2 À/À MEF with retrovirally expressed p100 restored LTbR-inducible RelA and RelB DNA binding activities and RelA translocation ( Figure 3B , lanes 5-8) concomitant with p100 degradation ( Figure S3A ). Interestingly, reconstitution of nfkb2 À/À cells with the processed p52 protein did not restore signal inducible RelA nuclear activity indicating the requirement for the IkB-like ankyrin repeat domain of p100 ( Figure 3B, lanes 13-16) . Further, The requirement of specific domains of p100 in LTbR-induced NF-kB/RelA activation was examined. NF-kB/RelA activation was scored by EMSA (top panel) and by immunoblotting (bottom panels) nuclear extracts prepared from LTbR agonist treated nfkb2 À/À MEF or nfkb2 À/À MEF stably transduced with retrovirus expressing full-length p100, a mutant that lacks the C-terminal stimulus-responsive phosphorylation sites (''p100 1-774 ''), a C-terminal truncated protein that lacks the IkB-like domain (''p52''), or an N-terminal truncated protein that lacks RHD (''IkBd''). (E) LTbR-induced proteolysis of pre-existing or de novo synthesized p100 protein was monitored using pulse-chase in vivo labeling. N-terminal p100 antibody was used in immunoprecipitates with extracts prepared from prelabeled cells at the indicated time points of an LTbR time course (lanes 1-3, ''chase''), and from cells labeled during the later phase of mock or LTbR time course (lanes 4 and 5, ''pulse''). Similarly treated extracts from nfkb2
À/À cells (lane 6) served to identify nonspecific bands. (F) Multiple nfkb2 p100 NF-kB complexes are functionally distinct: we propose to distinguish between self-inhibited dimeric complexes of p100 and RelA or RelB, which are unresponsive to LTbR signaling, and stimulus-responsive ternary complexes in which the IkBd domain of p100 inhibits functional RelA:p50 and RelB:p50 dimers in trans.
(G) Increased p52 association with p100 following LTbR signaling. Immunoblot for p52/p100 proteins of p100 C-terminal domain immunoprecipitates prepared from indicated cell extracts.
a mutant form of p100 lacking the C-terminal signal responsive phosphorylation sites also did not functionally complement the knockout cells ( Figure 3B , lanes 9-12). Strikingly, expression in nfkb2 À/À MEFs of the C-terminal portion of p100 containing the ankyrin repeat domain (IkBd) was sufficient for at least partial RelA:p50 activation upon LTbR ligation ( Figure 3B, lanes 17-20) .
To examine whether nfkb2 p100 is sufficient for NF-kB/ RelA activation or the canonical IkB proteins are also required, ikba Figures S3E and S3F) . Furthermore, we found that LTbR signaling to NF-kB was abrogated in ikb Figure 3C, lanes 9-12) . Collectively, these analyses provide biochemical and genetic evidence for the requirement and sufficiency of p100 as a stimulus-specific regulator of RelA dimers in response to noncanonical signaling triggered by LTbR stimulation.
Multiple nfkb2 p100 NF-kB Complexes Are Functionally Distinct Unlike canonical IkBs, nfkb2 p100 is not only capable of interacting with RelA:p50 dimers in trans via its IkBd domain as revealed by DOC-treated extracts analyzed by EMSA ( Figure 2E ), it can also dimerize with other NF-kB proteins via its Rel homology domain (RHD). Thus p100 is capable of forming complexes with NF-kB of distinct molecular architectures. To characterize the architecture of the complex(es) relevant for noncanonical signaling, we mapped DOC-sensitive and -insensitive interactions between RelA and p100 during LTbR signaling ( Figure 3D ). In resting cells (lanes 1-6), we found that most but not all p100 could be DOC-stripped off immunoprecipitated RelA proteins (top panel). In contrast, in LTbR-stimulated cells (lanes 7-12), no DOC-sensitive p100 could be detected in the RelA immunoprecipitate, while the DOCresistant fraction remained. Efficient stripping of IkBa and retention of p50 in the RelA immunoprecipitate confirmed the specificity of the DOC strip conditions. Similar analyses of canonical IkBa/b/3-deficient cells ( Figure S3G ) also revealed that DOC-sensitive p100-RelA complexes are responsive to LTbR signaling.
Given that the IkBd domain is genetically sufficient for LTbR induction of RelA:p50 dimer ( Figure 3B ), we examined biochemically the fate of the p100 RHD during noncanonical signaling. To this end, cellular proteins were pulse labeled with 35 S-methionine before adding the receptor agonist. Immunoprecipitates obtained with an N-terminal p100 RHD antibody revealed 35 S-labeled p100 prior to stimulation ( Figure 3E, lane 1) . Interestingly, LTbR stimulation led to the conversion of this pre-existing p100 to a polypeptide (lane 2) of the same molecular weight as the p52 generated de novo during LTbR signaling (lane 5). However, while de novo generated p52 protein participates in the LTbR-induced NF-kB DNA binding activities ( Figure S1C ), the p52 protein generated from pre-existing p100 complexes does not ( Figures 1C and S3C) .
To summarize our data we propose the following molecular architectures of p100 complexes ( Figure 3F ). LTbR-unresponsive complexes of p100 include the previously identified ''self-inhibited'' p100:RelA, p100:RelB, p100:p50, and p100:p52 dimers in which the IkBd domain of p100 folds back onto the dimer to inhibit its DNA binding activity in cis (Beinke and Ley, 2004; Mercurio et al., 1993; Naumann et al., 1993) . In addition, two p100 proteins may form a necessarily asymmetric dimer, analogous to two p105 proteins (Moorthy and Ghosh, 2003; Moorthy et al., 2006) . In that complex, one of the IkBd domains would inhibit the DNA binding activity of the p52 homodimer, while the other IkBd domain would be available to inhibit a RelA:p50 or a RelB:p50 dimer. Our results suggest that this second IkBd domain is sensitive to LTbR signaling to undergo proteolysis leaving the C-terminal RHD intact. The remaining p100:p52 complex would be self-inhibited and therefore incapable of participating in NF-kB DNA binding activity. However, during the later phase of LTbR signaling de novo synthesized p52 dimerizes with Rel proteins via the RHD and contributes to nuclear DNA binding activity as previously observed (Dejardin et al., 2002; Muller and Siebenlist, 2003) .
Based on these proposed functional roles of distinct p100 complexes, we would predict that the amount of p52 protein associated with p100 increases during the early phase of LTbR signaling. Indeed, immunoprecipitation of p100 with an antibody specific for the C-terminal IkBd domain yields more coprecipitating p52 protein at the 5 hr time point of LTbR signaling than in resting cells ( Figure 3G ).
Noncanonical Signaling to NF-kB/RelA Activation Activation of RelB dimers in the noncanonical signaling pathway was shown to depend on signal-responsive NIK-dependent activation of IKK1 (Beinke and Ley, 2004; Senftleben et al., 2001; Xiao et al., 2001 ). We asked if IKK1 is also required for activation of RelA dimers in response to LTbR signaling. Consistent with previous analyses (Derudder et al., 2003) , ikk1 À/À MEF did not show processing of p100 upon LTbR activation, and this could be restored upon retroviral reconstitution (Figure S4A) . Whereas TNF activation of NF-kB was unaffected ( Figure 4A , bottom panel), we did not detect inducible NF-kB activity containing either RelA or RelB in IKK1-deficient cells in response to LTbR signaling (top panel). Similarly, MEF derived from NIK knockout mice or from the alymphoplasia mutant mouse strain (NIKaly), which contains an inactivating mutation in NIK (Shinkura et al., 1999), showed not only a complete abrogation of RelB but also RelA dimer activation upon LTbR stimulation ( Figures 4B and S4B) . Furthermore, shRNA mediated knockdown of NIK by lentiviral vectors in ikba Figure S4C ) dramatically reduced RelA activation in response to LTbR engagement ( Figure 4C ). These results support the notion that noncanonical signaling via NIK and IKK1 regulates the degradation of nfkb2 p100 to affect NF-kB/RelA activation. A hallmark of canonical NF-kB signaling is the requirement for NEMO in inflammatory stimulus-responsive degradation of canonical IkB proteins. However, p100 processing to p52 upon LTbR activation was found to be intact in nemo À/À MEF (Dejardin et al., 2002; Muller and Siebenlist, 2003) . Our EMSA analysis confirmed that nemo À/À MEF fail to induce NF-kB activity upon TNF treatment ( Figure S4D ), but we found strong induction of NF-kB DNA binding activity in response to LTbR treatment ( Figure 4D ). DNA binding analysis performed in the presence of RelB or RelA supershift antibody revealed that both RelA:p50 and RelB:p50 activities remained inducible in the absence of NEMO (Figures 4E and S4E) .
Our results suggest a new model for the activation mechanism of NF-kB/RelA dimers in response to LTbR signaling. While LTbR signaling was proposed to bifurcate into the NEMO-IKK2-IkB-RelA and the IKK1-p100-RelB axes, our new understanding of the pathway suggests that p100 is associated with pre-existing RelA:p50 and RelB:p50 dimers ( Figure 4F ). NIK and IKK1 regulate the signal-responsive proteolysis of p100/IkBd, which results in nuclear RelA:p50 and RelB:p50 DNA binding activity in a NEMOindependent manner. Continued synthesis and processing of p100 to p52 may enhance the level of p52 containing NF-kB DNA binding complexes at later time points (Dejardin et al., 2002; Muller and Siebenlist, 2003) .
By investigating the mechanisms responsible for RelA dimer activation upon LTbR stimulation, we identified p100 as a stimulus-selective signal transducer that satisfies two criteria of bona fide IkB proteins: the ability to (1) sequester latent NF-kB dimers and (2) release the bound dimers via stimulus-induced proteolysis. While p100/IkBd is a bona fide IkB protein, it differs from the canonical IkB proteins IkBa, -b, and -3 in its ability to sequester not only RelA-but also RelB-containing dimers and in its responsiveness to noncanonical (e.g., LTbR, BAFFR) rather than canonical (e.g., TNFR and TLR) signaling pathways. Thus, we propose to distinguish between the canonical IkB proteins IkBa, -b, and -3 and the noncanonical IkB protein p100/IkBd.
Mathematical Reconstruction of Noncanonical
Signaling to NF-kB/RelA Our new understanding expands the NF-kB signaling module to include nfkb2 p100/IkBd as a fourth IkB that controls NF-kB/RelA activity in response to noncanonical, IKK1-inducing stimuli ( Figure 5A ). Studies of the dynamic behavior of the canonical IkB proteins have resulted in important insights about NF-kB signaling and stimulusspecific gene expression (Hoffmann et al., 2002; Kearns et al., 2006; Werner et al., 2005) in response to inflammatory stimuli. To investigate how the dynamics of p100 regulation affect RelA activation in response to noncanonical signaling, we described the synthesis, degradation, and molecular interactions of p100 with ordinary differential equations (see Supplemental Data) and included them in a mathematical model that already recapitulated TNF and LPS signaling. The resulting model (version 3.0) includes 98 biochemical reactions, which were parameterized based on published measurements, our own measurements, and fitting procedures. For p100 in particular, we measured mRNA and protein levels and their half-lives in resting cells and in response to NF-kB inducing stimuli (V. Shih, J.K., S.B., A.H., data not shown). Transcriptional and translational synthesis and degradation rate constants were fitted to these measurements.
The resulting in silico model of the NF-kB signaling module predicts NF-kB/RelA:p50 activity in response to either canonical or noncanonical stimuli, as well as the abundance of the 31 model components including the IkB proteins, free or complexed to IKK or NF-kB, in either the cytoplasm or the nucleus ( Figure S5 and Supplemental Data). Simulations of LPS and TNF pulse stimulations show the dynamics of NF-kB activities and cellular canonical IkB levels ( Figure 5B , left and center columns) that match previous measurements (Werner et al., 2005) . Unlike the canonical IkB proteins, NF-kB p100 is not degraded in response to IKK2-mediated inflammatory signals (Figure 5B, bottom row) . In contrast, IKK1-mediated LTbR signaling results in p100 degradation while the canonical IkB proteins are unaffected ( Figure 5B , right column). Most importantly, the model recapitulates our measurements of slow induction of nuclear NF-kB/RelA activity that reaches a maximum at 5-15 hr ( Figure S1B ).
Crosstalk between Canonical and Noncanonical Signaling
Given that nfkb2 p100, like IkBa and IkB3 (Kearns et al., 2006) , is an NF-kB target gene, we used computational simulations to explore feedback regulation and the dynamics of p100 protein levels in a variety of stimulation regimes. Remarkably, we found that a 1 hr pulse of TNF stimulation resulted in an elevation of p100 protein of about 4-fold that persisted for more than 20 hr ( Figure 6A , top graph). In contrast, graphing the sum of all canonical IkB proteins revealed the expected transient trough and rapid recovery. In sum, the model predicted that the fraction of p100-associated RelA protein at the 20 hr time point to be increased 3-to 4-fold ( Figure 6A, bottom graph) .
We examined these predictions experimentally. Immunoblotting of total cellular IkB protein confirmed that p100 protein is induced by 1 hr TNF pulse stimulation, while the levels of canonical IkB proteins were not discernibly different ( Figure 6B ). By quantitating IkB-NF-kB interactions with the DOC-EMSA assay coupled to immunodepletions, we found that TNF-primed cells contained much more p100-NF-kB complexes than unstimulated/ naïve cells ( Figure 6C ). These data confirm the model's prediction that priming of cells can shift the balance of latent NF-kB associated with canonical or noncanonical IkB proteins.
This shift in the IkB homeostasis may have functional consequences. Computational simulations of LTbR signaling in naïve and TNF-primed cells led to the prediction that primed cells may respond with a stronger NF-kB activation profile ( Figure 6D ). This prediction is remarkable because in the simulated stimulation regimen canonical signaling has long ceased when cells are exposed to agonist antibody, and it thus not only constitutes an example of signaling crosstalk but also of cellular memory. We examined the prediction experimentally. Our EMSA and nuclear Immunoblot results confirmed that 2-to 3-fold more NF-kB/RelA activity is induced by LTbR stimulation in cells that were previously primed with TNF ( Figures 6E  and 6F) .
We investigated the gene-expression effects of this elevated NF-kB response using quantitative multiplex RNase protection assays. While naïve MEF did not show appreciable inflammatory gene activation in response to the LTbR stimulation, primed MEF exhibited induction not only of the IkBa gene, a hallmark of the canonical NF-kB response, but also the gene encoding the inflammatory cytokine TNF ( Figure 6G ). These results constitute qualitative changes in stimulus-responsive gene expression programs. Our computational simulations of the NFkB signaling module revealed that the homeostatic control of IkB signal transducers integrates the history of cellular exposure to NF-kB inducing stimuli. Our experimental results confirmed the validity of the proposed model and resultant crossregulatory mechanism between canonical and noncanonical NF-kB inducing signals and revealed that its functional consequences for stimulus-specific gene expression programs may be profound.
Genetic Perturbations of IkB Homeostasis
The homeostasis of canonical and noncanonical IkB proteins may not only be subject to physiological stimuli, but altered homeostasis due to genetic aberrations may be the underlying cause for pathological misregulation of stimulus-specific gene expression. To examine this possibility and further test the validity of our mathematical model, we used computational simulations to predict the relative amounts of p100 protein in a panel of cells deficient for one or more canonical IkB proteins. For example, cells deficient in IkBa were predicted to have 2-fold more p100 protein than wild-type cells ( Figure 7A ). Similarly, doubly-deficient and triply-deficient cells are predicted to show further increases in p100 except for IkBb/3-deficient cells, in which p100 levels were predicted to be near wild-type. Immunoblotting for p100 with extracts derived from these different cell lines confirmed this prediction ( Figure 7B ); in particular, we observed no significant increases in p100 levels in IkBb/3-deficient cells while immunoblot signals were elevated in other knockouts as predicted.
Altered balances in the canonical and noncanonical IkB proteins may be expected to lead to alterations in the LTbR responsiveness. Computational simulations indeed predicted that NF-kB/RelA responses to agonist receptor would be highest in IkB triple-knockout and IkBa/3-deficient cells, intermediate in IkBa-and IkBa/b-deficient cells, and relatively low in wild-type and IkBb/3-deficient cells ( Figure 7C ). The results from experimental analysis using EMSA of nuclear extracts prepared from LTbRstimulated cells of each respective genotype were in overall agreement with these simulations ( Figure 7D ). These results suggested that genetic alterations in cells that constitutively alter the homeostasis of canonical and noncanonical IkB proteins affect the stimulus-specific activation of NF-kB. To determine whether these changes are functionally relevant, we examined the expression of known NF-kB response genes. Indeed, we found that cells that showed hyperresponsive NF-kB/RelA activation to LTbR stimulation also exhibited inflammatory gene expression, such as those encoding iNOS, MIP-2, IP-10, KC, or GM-CSF, not normally seen in wild-type MEF ( Figure 7E ). These effects were not merely quantitative but qualitative. Of the six target genes we examined we found a range of responsiveness that suggests that NFkB target genes may have different threshold requirements for NF-kB activity that allow for differential regulation.
Canonical and Noncanonical IkBs in Physiology and Pathology
Our results offer a significant revision of our understanding of NF-kB signaling. By examining the mechanism for NF-kB/RelA activation in response to LTbR signaling, we identified nfkb2 p100 as the pertinent signal transducer that functions as a bona fide IkB molecule. We propose that as a feedback regulator of the RelA:p50 transcriptional activator the noncanonical IkB protein p100 represents an integrator of canonical and noncanonical signals. The resulting signaling crosstalk between inflammatory and developmental stimuli suggests that the canonical and noncanonical NF-kB signaling pathways (previously described as separate) ought to be considered as being contained within a single signaling module. The ''four IkB'' computational model that integrates IKK1-and IKK2-mediated signals represents a first attempt in that direction. Future efforts will have to quantitatively address the regulation of RelB complexes and the generation of p52-containing dimers.
Within their physiological environment, cells receive multiple signals, and thus the potential for signaling crosstalk is significant. Relevant to lymphnode development, constitutive TNF signaling has been observed in the spleen (Schneider et al., 2004) . Indeed, the in vitro generation of fibroblast reticular cells from lymphnode tissue requires both TNFR and LTbR stimulation (Katakai et al., 2004) , while abrogation of TNF signaling in vivo results in the loss of lymphnode architecture (Rennert et al., 1998) . Fundamentally, all cells are continuously subject to low or varying amounts of TLR/TNFR signaling, albeit these conditions are not usually reproduced in sterile in vitro cell-culture conditions. Recent in vivo studies suggest that naïve T cell responses are regulated by integrating signals from memory and regulatory T cells via p100 (Ishimaru et al., 2006) . Remarkably, nfkb2 p100-mediated crosstalk does not have to occur coincidently but integrates the history of cellular exposure to inflammatory signals.
Conversely, our studies demonstrate that alterations in the homeostasis of IkB proteins can result in inappropriate expression of inflammatory genes in response to developmental/noncanonical LTbR signaling. We utilized defined genetic mutants with altered IkB protein expression patterns. These cells may serve as model systems for disease-associated misregulation. In this context, it is of interest to note that a significant fraction of malignant Reed Sternberg cells in Hodgkin's lymphoma has defective IkBa genes (Krappmann et al., 1999) . Our findings suggest that pathogenic misregulation of gene expression in Reed Sternberg cells may in part be the result of noncanonical developmental signals impinging on an NF-kB signaling module with an altered homeostasis of IkB proteins. We suggest that the integration of multiple signals via signaling crosstalk represents an opportunity for therapeutic intervention, which may be more effectively exploited through the combined tools of computational modeling and biochemical analysis.
EXPERIMENTAL PROCEDURES
Cell Culture and Reagents Primary and 3T3 immortalized MEF were generated from E12.5-14.5 embryos and maintained as previously described (Hoffmann et al., 2003) . Generation of ikba lines will be described elsewhere. Agonistic LTbR monoclonal antibody raised in hamster (AF.H6) was obtained from Jeff Browning (Biogen, Inc). Two other previously used Rat anti-LTbR antibodies, 3C8 and 4H8 (Dejardin et al., 2002) , were also used ( Figure S1F ). Recombinant murine TNF was from Roche. RelA/p65 (sc-372), RelB (sc-226), cRel (sc-71), IkBa (sc-371), IkBb (sc-946), and NIK (H-248) antibodies were from Santa Cruz Biotechnology. Phospho-IkBa (Ser-32 and Ser-36) monoclonal antibody was from Cell Signaling Technology. N-terminal p52 (1495), p50 (1157 and 1263) as well as C-terminal anti-sera for p100 (1310) and p105 (1140) were a generous gift from Nancy Rice. Antiserum against TAF20 was used to test nuclear fractionation. Sc-372G antibody was used for RelA immunoprecipitation and sc-226 crosslinked to protein-A-sepharose beads was used for RelB immunoprecipitate. Supershift antibodies have been described previously (Hoffmann et al., 2003) .
Immunoblot, Immunoprecipitation, and Kinase Assay Whole-cell extracts were prepared in RIPA buffer and normalized before immunoblot analysis. For immunoprecipitation-western analysis, whole-cell lysate from 10 6 cells was prepared in buffer containing 20% glycerol, 0.2 mM EDTA, 0.5% NP-40, and 150 mM NaCl. Band intensities were quantitated by phosphor-imager and normalized against the respective actin band. To evaluate the DOC sensitivity of RelA-p100 interactions, RelA immunoprecipitates obtained from cytosolic extract were washed with buffer containing 10 mM HEPES-KOH, pH 7.9, 150 mM KCl, 1 mM EDTA, and 0.1% NP-40 containing 0%, 0.3%, or 0.8% deoxycholate. Washes and SDS sample buffer-eluted immunopellets were immunoblotted. IKK kinase assays were performed as described (Werner et al., 2005) .
Pulse-Chase Metabolic Labeling
In vivo pulse labeling of MEF was done with 100 mCi/ml trans 35 S-Met label (MP Biomedicals, Inc.) using the indicated time courses. p52/ p100 were immunoprecipated (N-terminal antiserum 1495) from RIPA lysate. Proteins were resolved in 8% SDS-PAGE and visualized by autoradiography.
Retrovirus Mediated Gene Transduction IKK1 and p100, p100 1-774 or p52 expressing retroviral constructs were gifts from M. Karin and A. Rabson. pBabe.IkBd.puro was constructed by PCR amplifying C-terminal region of p100 encoding amino acids (483-934) using pBabe.p100.puro as template. Retroviral constructs were cotransfected with pCL.Eco into 293T cells, and 42 hr posttransfection filtered supernatant was used to infect MEF. Transduced cells were selected with puromycin hydrochloride (Sigma).
Lentiviral Delivery of shRNA Lentiviral constructs expressing shRNAs against nfkb2 and nik genes and control oligos were packaged into viruses as described previously (Tergaonkar et al., 2005) . Sequences for specific oligo used in knockdown studies are available upon request. Four different control shRNA were used ( Figure S2E ) to ensure functional specificity.
TAP-p65 Complex Purification and Mass Spectrometry
Murine rela gene was cloned into pRAV-Flag-TAP bicistronic retroviral vector that expresses EGFP from an internal ribosome entry site (IRES) promoter (Knuesel et al., 2003) . Tagged 
DNA Binding Assays
EMSAs were done as described with a kB site containing probe that binds to both RelA and RelB dimer with similar affinities (Lo et al., 2006) . Super-shift assays were done with antibodies as described before (Hoffmann et al., 2003) . For DOC sensitivity, 2 mg of cytosolic extract was treated with final 0.8% DOC for 30 min and subsequently subjected to EMSA analysis. Where specified, cytosolic extracts were immunodepleted for indicated protein prior to DOC treatment.
RNase Protection Assays
Total RNA was extracted from stimulated fibroblast using Trizol reagent. RPA was performed with 5 mg RNA using Riboquant probe set (BD-Bioscience) according to manufacturers' protocols.
Computational Modeling
The previously described mathematical model (Werner et al., 2005) was extended to include nfkb2 p100 and noncanonical signaling via IKK1 as shown in Figure S5 and described in detail in the Supplemental Data. Simulations were done in Matlab version 2006a (Mathworks) using the built-in ode15s solver at default settings.
Supplemental Data
Supplemental Data include five figures, four tables, Supplemental Experimental Procedures, and Supplemental References and can be found with this article online at http://www.cell.com/cgi/content/full/ 128/2/369/DC1/.
